CA2282442A1 - Cosmetic product - Google Patents
Cosmetic product Download PDFInfo
- Publication number
- CA2282442A1 CA2282442A1 CA002282442A CA2282442A CA2282442A1 CA 2282442 A1 CA2282442 A1 CA 2282442A1 CA 002282442 A CA002282442 A CA 002282442A CA 2282442 A CA2282442 A CA 2282442A CA 2282442 A1 CA2282442 A1 CA 2282442A1
- Authority
- CA
- Canada
- Prior art keywords
- acid
- skin
- composition
- product according
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Jellies, Jams, And Syrups (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A cosmetic product is provided for delivery of skin actives through adhesive strips which concurrently remove keratotic plugs from skin pores. The product is a strip including a flexible substrate sheet onto which a composition containing an adhesive polymer is deposited. The composition is essentially a polymer of anionic, cationic, nonionic, amphoteric or zwitterionic variety which increases in tackiness upon being wetted, with wetting occuring just prior to application onto the skin thereby enhancing the composition's adhesivity. Skin agents delivered through the adhesive strip include vitamins, herbal extracts, alpha- and beta-hydroxycarboxylic acids, ceramides, anti-inflammatories, antimicrobials, vasoconstrictors, zinc salts and mixtures thereof. The strips are sealably enclosed within a pouch for purposes of moisture protection.
Description
COSMETIC P ODUCT
BACKGROUND OF THE INVENTION
Field of the Invention The invention concerns a cosmetic product applied to the skin for removing keratotic plugs from pores and concurrent delivery of skin benefit agents.
The Related Art A variety of vehicles exist for delivery of actives to the skin. These vehicles may be lotions, creams, pads, sprays and even masks. Some are leave-on systems while others are intended as short-lived wash-off products. Those who practice cosmetic arts know the critical role that vehicles perform in delivering actives effectively to skin.
Delivery is not the only concern. Some types of actives are degraded by the vehicle. For instance, ascorbic acid, also known by its common name of Vitamin C, is a very unstable substance. Although readily soluble in water, rapid oxidation occurs in aqueous media. Solubility of ascorbic acid has been reported to be relatively poor in nonaqueous media, thereby preventing an anhydrous system from achieving a significant level of active concentration. Derivatives have been produced with greater stability than the parent component. See U.S. Patent 5,237,723 (Yamamoto et al.) and U.S. Patent 5,078,989 (Ando et al.). A two-pack approach ' has been developed where Vitamin C powder and other ingredients are separately packaged in different containers with mixing just prior to use. See U.S. Patent 4,818,521 (Tamabuchi).
J6440 (C) WO
BACKGROUND OF THE INVENTION
Field of the Invention The invention concerns a cosmetic product applied to the skin for removing keratotic plugs from pores and concurrent delivery of skin benefit agents.
The Related Art A variety of vehicles exist for delivery of actives to the skin. These vehicles may be lotions, creams, pads, sprays and even masks. Some are leave-on systems while others are intended as short-lived wash-off products. Those who practice cosmetic arts know the critical role that vehicles perform in delivering actives effectively to skin.
Delivery is not the only concern. Some types of actives are degraded by the vehicle. For instance, ascorbic acid, also known by its common name of Vitamin C, is a very unstable substance. Although readily soluble in water, rapid oxidation occurs in aqueous media. Solubility of ascorbic acid has been reported to be relatively poor in nonaqueous media, thereby preventing an anhydrous system from achieving a significant level of active concentration. Derivatives have been produced with greater stability than the parent component. See U.S. Patent 5,237,723 (Yamamoto et al.) and U.S. Patent 5,078,989 (Ando et al.). A two-pack approach ' has been developed where Vitamin C powder and other ingredients are separately packaged in different containers with mixing just prior to use. See U.S. Patent 4,818,521 (Tamabuchi).
J6440 (C) WO
Water compatible alcohols such as propylene glycol, polypropylene glycol and glycerol have been used as co-carriers alongside water to improve stability. See U.S.
Patent 4,983,382 (Wilmott and Znaiden).
Vitamin C is just one example of difficult to formulate cosmetic ingredients. Many other types of vitamins, herbal extracts and alpha- or beta- hydroxycarboxylic acids have one or more properties which render them sensitive to certain types of delivery vehicles.
Masks have been employed to deliver herbal extracts to the face. Among the extracts have been glycyrrhizinic acid, a-bisabolol, azulene, yarrow, coltsfoot, sage, myrrh, rosemary and others. See U.S. Patent 5,614,201 and U.S. Patent 5,482,710, both to Slavtcheff et al. These mask products are reported to eliminate pimples, blemishes and the redness of acne. Unfortunately delivery via masks requires the presence of significant amounts of water which may adversely react with moisture sensitive ingredients. Extended drying times are also necessary for evaporation of water from the applied mask material. Finally, masks have relatively low adhesivity. These products are insufficiently sticky to effect "rip-off" of pore plugs and accumulated dead skin cells which otherwise would be barriers or at least hindrances to the penetration of the cosmetic actives.
Austrian Patent 206114 describes a preparation for removing fine lines and wrinkles by stretching the skin. The preparation consists of facial anatomically fitted sheets of silk tissue soaked with polyvinyl alcohol and coated with a paste containing either a placenta extract and/or vitamins such as Vitamin B8. Another relevant disclosure is EP 0 309 309 A which reports a flexible mesh sheet supporting a hydratable gel. Upon application to the skin, the gel is A~I~~IDLD SHEET
J6440 (C) WO
- 2a -rehydrated at least partially while the mesh through its natural flexibility molds to the irregularities of the face.
Upon drying under the influence of normal skin temperature, the dry form adheres to the skin until a user peels away the resultant mask.
Within the last two years, cleansing pore strips have entered commerce in a number of countries. Products such as Kao Biore~ and Pond's~ Cleansing Pore Strips are sheets of an adhesive coated flexible band-aid shaped strip which when wetted have sufficient adhesivity to remove keratotic plugs from skin pores. The strips are left on the skin for approximately 15-30 minutes to allow adhesive polymer to penetrate the pores. Removal of the strip rips away the ~ENp~p S,~,r~
Patent 4,983,382 (Wilmott and Znaiden).
Vitamin C is just one example of difficult to formulate cosmetic ingredients. Many other types of vitamins, herbal extracts and alpha- or beta- hydroxycarboxylic acids have one or more properties which render them sensitive to certain types of delivery vehicles.
Masks have been employed to deliver herbal extracts to the face. Among the extracts have been glycyrrhizinic acid, a-bisabolol, azulene, yarrow, coltsfoot, sage, myrrh, rosemary and others. See U.S. Patent 5,614,201 and U.S. Patent 5,482,710, both to Slavtcheff et al. These mask products are reported to eliminate pimples, blemishes and the redness of acne. Unfortunately delivery via masks requires the presence of significant amounts of water which may adversely react with moisture sensitive ingredients. Extended drying times are also necessary for evaporation of water from the applied mask material. Finally, masks have relatively low adhesivity. These products are insufficiently sticky to effect "rip-off" of pore plugs and accumulated dead skin cells which otherwise would be barriers or at least hindrances to the penetration of the cosmetic actives.
Austrian Patent 206114 describes a preparation for removing fine lines and wrinkles by stretching the skin. The preparation consists of facial anatomically fitted sheets of silk tissue soaked with polyvinyl alcohol and coated with a paste containing either a placenta extract and/or vitamins such as Vitamin B8. Another relevant disclosure is EP 0 309 309 A which reports a flexible mesh sheet supporting a hydratable gel. Upon application to the skin, the gel is A~I~~IDLD SHEET
J6440 (C) WO
- 2a -rehydrated at least partially while the mesh through its natural flexibility molds to the irregularities of the face.
Upon drying under the influence of normal skin temperature, the dry form adheres to the skin until a user peels away the resultant mask.
Within the last two years, cleansing pore strips have entered commerce in a number of countries. Products such as Kao Biore~ and Pond's~ Cleansing Pore Strips are sheets of an adhesive coated flexible band-aid shaped strip which when wetted have sufficient adhesivity to remove keratotic plugs from skin pores. The strips are left on the skin for approximately 15-30 minutes to allow adhesive polymer to penetrate the pores. Removal of the strip rips away the ~ENp~p S,~,r~
plugs as well as a layer of skin. These products do not contain any skin benefit agents. In fact, the whole concept behind the strips is removal rather than deposition.
It is an object of the present invention to provide a delivery system for vitamins, herbal extracts and hydroxycarboxylic acids which assists penetration of these actives into the human skin.
Another object of the present invention is to provide a delivery system for vitamins, herbal extracts and hydroxycarboxylic acids which does not interfere or degrade the active during storage.
These and other objects of the present invention will become more readily apparent through the following summary, detailed discussion and examples.
SUMMARY OF THE INVENTION
A cosmetic product for delivery of skin actives is provided which includes:
(A) a strip including:
(i) a flexible substrate sheet; and (ii) a composition containing a polymer selected from the group consisting of anionic, cationic, nonionic, amphoteric, zwitterionic and polymer mixtures thereof deposited onto the substrate sheet, the composition further including an active selected from the group consisting of vitamins, herbal extracts, alpha- and beta-hydroxycarboxylic acids, ceramides, anti-inflammatories, antimicrobials, vasoconstrictors, zinc salts and mixtures thereof; the composition increasing in tackiness upon being wetted just prior to use thereby enhancing the composition adhesivity to skin; and (B) a pouch sealably enclosing the strip.
DETAILED DESCRIPTION OF THE INVENTION
Now it has been discovered that adhesive strips designed to remove keratotic plugs are exceptional vehicles for the delivery of active ingredients into the skin. Actives covered by the present invention are vitamins, herbal extracts, alpha- and beta- C,-C3o hydroxycarboxylic acids, ceramides, anti-inflammatories, anti-microbials, vasoconstrictors, zinc salts and mixtures thereof.
Vitamins covered by the present invention include Vitamin A, Vitamin B, Vitamin C, Vitamin E and combinations thereof.
Most preferred is Vitamin C which not only is defined as including ascorbic acid but also salts and esters thereof such as magnesium ascorbyl phosphate, ascorbyl palmitate, L-ascorbyl stearate, dehydroascorbic acid, Vitazyme C and combinations thereof. Adhesive carriers of the present invention are particularly useful for Vitamin C delivery because it is very unstable in the presence of water yet relatively poorly soluble in non-aqueous media. These problems are overcome in the present carrier system where during manufacture Vitamin C contacts an aqueous media for only a short period of time to allow transfer onto a flexible substrate. Almost all the water is removed immediately thereafter. The final product may contain less than 20~ water, but usually less than 10°s, optimally less than 7~ water.
.~
It is an object of the present invention to provide a delivery system for vitamins, herbal extracts and hydroxycarboxylic acids which assists penetration of these actives into the human skin.
Another object of the present invention is to provide a delivery system for vitamins, herbal extracts and hydroxycarboxylic acids which does not interfere or degrade the active during storage.
These and other objects of the present invention will become more readily apparent through the following summary, detailed discussion and examples.
SUMMARY OF THE INVENTION
A cosmetic product for delivery of skin actives is provided which includes:
(A) a strip including:
(i) a flexible substrate sheet; and (ii) a composition containing a polymer selected from the group consisting of anionic, cationic, nonionic, amphoteric, zwitterionic and polymer mixtures thereof deposited onto the substrate sheet, the composition further including an active selected from the group consisting of vitamins, herbal extracts, alpha- and beta-hydroxycarboxylic acids, ceramides, anti-inflammatories, antimicrobials, vasoconstrictors, zinc salts and mixtures thereof; the composition increasing in tackiness upon being wetted just prior to use thereby enhancing the composition adhesivity to skin; and (B) a pouch sealably enclosing the strip.
DETAILED DESCRIPTION OF THE INVENTION
Now it has been discovered that adhesive strips designed to remove keratotic plugs are exceptional vehicles for the delivery of active ingredients into the skin. Actives covered by the present invention are vitamins, herbal extracts, alpha- and beta- C,-C3o hydroxycarboxylic acids, ceramides, anti-inflammatories, anti-microbials, vasoconstrictors, zinc salts and mixtures thereof.
Vitamins covered by the present invention include Vitamin A, Vitamin B, Vitamin C, Vitamin E and combinations thereof.
Most preferred is Vitamin C which not only is defined as including ascorbic acid but also salts and esters thereof such as magnesium ascorbyl phosphate, ascorbyl palmitate, L-ascorbyl stearate, dehydroascorbic acid, Vitazyme C and combinations thereof. Adhesive carriers of the present invention are particularly useful for Vitamin C delivery because it is very unstable in the presence of water yet relatively poorly soluble in non-aqueous media. These problems are overcome in the present carrier system where during manufacture Vitamin C contacts an aqueous media for only a short period of time to allow transfer onto a flexible substrate. Almost all the water is removed immediately thereafter. The final product may contain less than 20~ water, but usually less than 10°s, optimally less than 7~ water.
.~
Vitamin A for purposes of this invention include retinol, retinoic acid as well as retinyl Cz-Cz2 fatty acid esters.
Most preferred among the esters are retinyl palmitate and . retinyl linoleate. Vitamin E may be provided in the form of tocotrienols, a-tocopherol, (3-tocopherol, y-tocopherol and 8-tocopherol. Included within the Vitamin E group are tocopheryl C2-C2z fatty acid esters including tocopheryl acetate, tocopherol linoleate and tocopheryl palmitate.
Vitamin B may be present in the form of thiamine, riboflavin, niacin, pantothenic acid, biotin, cobalamin, pyridoxine hydrochloric, pyridoxamine dihydrochloride, pyridoxal, pyridoxal phosphate, folic acid, inositol and mixtures as well as complexes thereof. Under the term vitamin may also be included thaproline, L-caritine, nicotinic acid, nicotinamide and cyproterone acetate.
Herbal extracts particularly suitable for the present invention are antioxidants or free-radical inhibitors.
Examples of these extracts include:
WO 98/42303 PCTlEP98/01423 _ 6 _ PLANT/EXTRACTS SOLUBILITY
W=WATER
O=OIL
basil leaf o and w bell a er o and w black tea extracts w blackber w black currant fruit w chamomile o carrot root o coffee seed w dandelion root o and w date alm fruit o and w echinacea ur urea o fennel o in ko leaf w insen o ra a seed o ra a skin o ra efruit o green tea polyphenyls (i.e. w including epicatechin gallate and a i allocaatechin 3-O- allate) a ali ids o har o o h tum o hawthorn berries w ' asmine o licorice w and o mar ' oram o rrh um resin o onion o ine bark o red clover flower o resveratrol o rosema o sa a w sesame o St. Johns wort o strawber w sweet ea w tomato o and w th a o Uva Ursi (bearber ) o vanilla fruit w bora a seed oil o wild bora a seed oil o Flavanoid Extracts hes eredin o ~neohesperidin ~ w uercetin o rutin -morin ' w kaem herol o ricetin w/o enistein o Ph toestro en Extracts coumestrol o estriol o h tosterols o Other Extracts limonene o etho uin o chloro enic acid w lutathione w h dro uinone o ubi uinone (coenz me Q) o li oic acid o N-acet 1 c steine o curcumin o Herbal extracts particularly effective for sebum/oil control include dill, horseradish, oats, neem, beet, broccoli, tea, pumpkin, soybean, barley, walnut, flax, ginseng, poppy, avocado, pea, sesame, dandelion, wheat, nettle, cashew, pineapple, apple, asparagus, Brazilnut, chickpea, grapefruit, orange, cucumber, buckwheat, strawberry, ginko, tomato, blueberry, cowpea and grape extracts.
Other herbal extracts also suitable are those of ivy horse chestnut, centella asiatica, rosmarinic acid, glycyrrizinate derivatives, alpha bisabolol, azulene and derivatives thereof, asiaticoside, sericoside, ruscogenin, escin, escolin, betulinic acid and derivatives thereof, catechin and derivatives thereof.
Alpha- and beta- hydroxycarboxylic acids ranging from Cz-C3o are also suitably delivered by the adhesive strips of the present invention. The beta-hydroxycarboxylic acids are primarily exemplified by salicylic acid and C1-C3o ester and _ g -salt derivatives. Examples of suitable alpha-hydroxycarboxylic acids include but are not limited to:
alpha hydroxy acetic acid (glycolic acid) alpha hydroxybenzeneacetic acid (mandelic acid) alpha hydroxypropionic acid (lactic acid) alpha hydroxybutanoic acid alpha hydroxyhexanoic acid alpha hydroxyoctanoic acid (alpha hydroxycaprylic acid) alpha hydroxynonanoic acid alpha hydroxydecanoic acid alpha hydroxyundecanoic acid alpha hydroxydodecanoic acid (alpha hydroxylauric acid) alpha hydroxytetradecanoic acid alpha hydrocyhexadecanoic acid alpha hydroxyoctadecanoic acid alpha hydroxyoctaeicosanoic acid;
dicarboxylic alpha hydroxy acids;
dihydroxybutanedioic acid (tartaric acid) 2-hydroxybutanedioic acid (malic acid) 2-hydroxy propanedioic acid 2-hydroxy hexanedioic acid 2-hydroxy octanedioic acid 2-hydroxy decanedioic acid 2-hydroxy dodecanedioic acid 2-hydroxy myristicdioic acid 2-hydroxy palmiticdioic acid Tricarboxylic alpha hydroxy acid;
2-hydroxy-1,2,3,-propanetricarboxylic acid (citric acid) 1-hydroxy-1,2,3-propanetricarboxylic acid (isocitric acid) and mixtures thereof.
C1-C3o esters and salts of alpha- and beta- hydroxycarboxylic acids (e. g. potassium , sodium, ammonium, triethanolammonium WO 98/42303 PCTlEP98/01423 - g -salts) are also meant to be included within the term "alpha-. and beta- hydroxycarboxylic acid". Depending on the pH of the composition, a mixture of the salt and the acid may be present.
The preferred alpha hydroxycarboxylic acids are monocarboxylic acids, in order to improve skin penetration and efficacy.
Even more preferably, the hydroxy acid is chosen from lactic acid, glycolic acid, mandelic acid, and mixtures thereof to optimize the efficacy of compositions by increasing percutaneous absorption. Most preferred is the L-form of an alpha hydroxycarboxylic acid.
Ceramides useful for the present invention are sphingolipids or phytosphingolipids including Ceramide 1, Ceramide 3 and Ceramide 6.
Anti-inflammatories of the present invention are illustrated by corticoids such as beta-methasone 17-acetate, indomethacin, ketoprofen, flufenamic acid, ibuprofen, diclofenace, diflunisal, fenclofenac, naproxen, piroxidam and sulindac. Antimicrobials illustrative of the present invention include, chlorohexidine, hexetidine, 3,4,4'-trichlorocarbanilide, (tricarbanilide) 2,4,4'-tricloro-2-hydroxydiphenyl ether (triclosan), cetyl pyridinium chloride, benzalkonium chloride, C~-Czo organoperoxy compounds (e.g, benzoyl peroxide) and mixtures. Vasoconstrictors are illustrated by compounds such as papaverine, yohimbine, ' visnadin, khellin, bebellin and nicotinate derivatives.
Zinc salts which may be effective include zinc thaproline, ' zinc chloride, zinc sulfate, zinc phenolsulfonate and zinc pyrithione. Other substances within one or more of the above categories of actives include resorcinol, azelaic acid, oxamic acid and cyoctol.
Actives of the present invention may range from 0.00002 to 40%, preferably from 0.01 to 20%, optimally from 0.1 to 10%
and in some instances from 1 to 8% by weight of the composition. Of course, vitamins and herbal extracts are usually employed at much lower levels than for instance the hydroxycarboxylic acids. Thus, vitamins may range from 0.0001 to 1%, preferably from 0.001 to 0.5% by weight for Vitamin A, Vitamin B and Vitamin E. Much higher levels may be tolerated for Vitamin C and these may range preferably from 0.01 to 40%, optimally from 0.1 to 30% by weight.
Preferably the amount of the hydroxycarboxylic acid component present in the composition according to the invention is from 0.5% to 20%, more preferably from 1% to 15%, and most preferably from 3.0% to 12.0% by weight of the composition.
Actives of the present invention will be formulated onto a flexible substrate sheet impregnated with an adhesive composition containing an anionic, cationic, nonionic, amphoteric or zwitterionic polymer. In a dry state, the composition preferably but not necessarily is non-tacky to the touch. The impregnated substrate sheet is sealably enclosed in a pouch, particularly a laminated foil package to control moisture level.
Pouches of the present invention are normally of the laminated foil variety. These are heat sealed and utilize foils with very low vapor (e. g. moisture) transmission rates (a rate of transmission less than 5% per day, preferably less than 1% per day volatile fluid gain or loss). Walls suitable for the pouch may utilize polyester, polyethylene or polypropylene sheets, several layers of which can be laminated together. These layers may also be provided with a coating of wax or other volatile fluid impermeable material.
The product is used by removing the strip from its usually individually wrapped pouch and either directly wetting the composition on the sheet or indirectly by wetting the face in areas to be contacted by the composition. In either instance, the wetting agent interacts with the composition so it becomes tacky and sufficiently mobile to flow into skin pores. The time between removal of strip from the pouch and use may be anywhere from 5 seconds to several hours, usually from 10 to 20 seconds. Pure water is the preferred wetting agent. However, other liquid systems or gels could be employed. Suitable wetting agents would include alcohols such as ethanol, propanol, propylene glycol, polyethylene glycol, polypropylene glycol and especially mixtures of these alcohols with water. Gels would normally consist of structured liquids (particularly water) thickened with structuring agents such as Carbomer.
Subsequent to wetting, the composition is allowed to dry over the area of treatment. During drying the keratotic plugs stickingly adhere to the composition. Advantageously the drying period ranges from 1 minute to 5 hours, preferably from 5 minutes to 1 hour, optimally from 10 to 20 minutes. Thereafter, the dried composition with adhered plugs is peeled from the skin.
Mobility of the composition may be measured by yield point.
The yield point should range from 1 to 400 Pascals, preferably from 20 to 200, optimally from 50 to 100 Pascals.
The composition will include an adhesive polymer which may either be anionic, cationic, nonionic, amphoteric, zwitter-ionic or mixtures thereof. Mixtures may be of polymers within any one categoxy or between different category types.
Illustrative of the latter, and a preferred embodiment, is a combination of an anionic and nonionic polymer.
Examples of nonionic polymers suitable for adhesive film deposition are the copolymers of vinyl acetate and crotonic acid, terpolymers of vinyl acetate, crotonic acid and a vinyl ester of an alpha-branched saturated aliphatic monocarboxylic acid such as vinyl neodecanoate; copolymers of methyl vinyl ether and malefic anhydride (molar ratio about 1.1) wherein such copolymers are 50°s esterified with a saturated alcohol containing from 1 to 4 carbon atoms such as ethanol or butanol; and acrylic copolymers, terpolymers, etc., containing acrylic acid or methacrylic acid esters of acrylic or methacrylic acid with one or more saturated alcohols having from 1 to 22 carbon atoms such as methyl methacrylate, ethyl acrylate, ethyl methacrylate, n-butyl acrylate, t-butyl acrylate, t-butyl methacrylate, n-butyl methacrylate, n-hexyl acrylate, n-octyl acrylate, lauryl methacrylate and behenyl acrylate, glycols having from 1 to 6 carbon atoms such as hydroxypropyl methacrylate and hydroxyethyl acrylate, styrene, vinyl caprolactam, vinyl acetate, acrylamide, alkyl acrylamides and methacrylamides having 1 to 8 carbon atoms in the alkyl group such as methacrylamide, t-butyl acrylamide and n-octyl acrylamide, and other compatible unsaturated monomers. One specific example is the emulsion polymerized terpolymer of methacrylic acid, n-butyl acrylate and ethyl acrylate (e. g., in a weight percent ratio of 31:42:27, respectively).
Further examples of nonionic adhesive polymers are homopolymers of N-vinylpyrrolidone and copolymers of ,.
N-vinylpyrrolidone with compatible nonionic monomers such as vinyl acetate and terpolymers of ethyl acrylate, butyl methacrylate and methyl methacrylate. Nonionic polymers containing N-vinylpyrrolidone in various weight average molecular weights are available commercially from ISP
Corporation such as homopolymers of N-vinylpyrrolidone having an average molecular weight of about 530,000 under the trademark PVP K-90 and those having an average molecular weight of about 1,000,000 sold under the trademark of PVP
K-120. Particularly preferred is poly(methyl vinyl ether/maleic anhydride) as an unneutralized resin available from ISP Corporation under the trademark Gantrez~ S-97 BF.
Anionic adhesive polymers often are derived from the nonionic types which include carboxylic acid functions.
Alkaline agents are employed to neutralize the carboxylic acid or anhydride transforming them into anionic salts.
Examples of suitable neutralizing agents include 2-amino-2-methyl-1,3-propanediol (AMPD);
2-amino-2-ethyl-1,3-propanediol (AEPD);
2-amino-2-methyl-1-propanol (AMP); 2-amino-1-butanol (AB);
monoethanolamine (MEA); diethanolamine (DEA);
triethanolamine (TEA); monoisopropanolamine (MIPA);
diisopropanol-amine (DIPA); triisopropanolamine (TIPA); and dimethyl stearamine (DMS). Most preferred is AMP.
Particularly preferred anionic polymers are the salts of poly(methyl vinyl ether/maleic anhydride) and polystyrene sulfonic acid. The former is obtained by at least partial neutralization of Gantrez~ S-97 BF and the latter available from the National Starch & Chemical Company under the trademarks Versa TL-501 and Flexan~ 130 having respective molecular weights of about 500,000 and 100,000. Other polymer films which may be employed and are commercially available as listed in the Table below.
TABLE I
POLYMER TRADEMARKS CTFA DESIGNATIONS
(SUPPLIER) Resyn~ 28-1310 (NSC) Vinyl acetate/crotonic acid copolymer Resyn~ 28-2930 (NSC) Vinyl acetate/crotonic acid/vinyl neodecanoate copolymer Resyn~ 28-2913 (NSC) Vinyl acetate/crotonic acid/vinyl neodecanoate copolymer Versatyl~ 40 (NSC) Octylacrylamide/acrylates copolymer Versatyl~ 42 (NSC) Octylaczylamide/acrylates copolymer Experimental Resin (NSC) Vinyl acetate/vinyl neodecanoate/maleic half-ester ',Ultrahold-8~ (BASF) Acrylate/acrylamide copolymer Luviset~ CAP (BASF) Vinyl acetate/crotonic acid/vinyl propionate copolymer PVP K-30 (ISP) PVP
PVP/VA E-335 (ISP) PVP/Vinyl acetate copolymer PVP/VA E-735 (ISP) PVP/Vinyl acetate copolymer Gantrez~ ES-225 (ISP) Ethyl ester of PVM/MA copolymer Gantrez~ ES-425 (ISP) Butyl ester of PVM/MA copolymer Gaffix~ VC-713 (ISP) Vinyl caprolactam/PVP/dimethyl aminoethyl methacrylate copolymer Cationic adhesive polymers suitable for the present invention may be prepared as homo- or copolymers from monomers including:
Dimethyl aminoethyl acrylate (DMAEA), Dimethylaminoethyl methacrylate (DMAEMA), Dimethylaminopropylacrylamide (DMAPAAm), and Dimethylaminopropyl methacrylamide (DMAPMAAm) which are all (meth)acrylamides or (meth)acrylic acid esters having a dialkylamino group;
,., Dimethylaminostyrene (DMASt) and Dimethyaminomethylstyrene (DMAMSt) and the like which are styrenes having a dialkylamino group;
4-Vinyl pyridine and 2-vinyl pyridine which are vinyl pyridines; and Quaternized products of these with a known quaternizing agent such as alkyl halide, benzyl halide, alkyl or aryl 20 sulfonic acid, or dialkyl sulfate.
Among suitable amphoteric adhesive polymers are those derived from monomers such as:
N-(3-sulfopropyl)-N-acryloyloxyethyl-N,N-dimethylammonium betaine, N-(3-sulfopropyl)-N-methacroylamidepropyl-N,N-dimethylammonium betaine, N-(3-carboxymethyl)-N-methacroylamidepropyl-N,N-dimethylammonium betaine and N-carboxymethyl-N-methacroylaxyethyl-N,N-dimethylammonium betaine.
When the salt forming group of the cationic and amphoteric polymers is not ionized, it is preferred to ionize it via neutralization with known acids such as hydrochloric acid and sulfuric acid which are inorganic acids; acetic acid, propionic acid, lactic acid, succinic acid, glycol acid which are organic acids, or with known bases such as triethylamine, trimethylarnine which are tertiary amines;
ammonia; or sodium hydroxide.
Most polymers suitable for the present invention will be relatively brittle when dried. Therefore, they require a supporting surface which is a flexible substrate sheet.
Substrate sheets of the present invention may either be occlusive or non-occlusive. Preferably but not necessarily the sheets are non-occlusive to allow water evaporation from the deposited polymer as the film maturates. Non-occlusivity or breathability is achieved either through use of a hydrophobic substrate having physical porosity (e. g.
pore channels) or a hydrophilic substrate wherein the material of construction inherently allows for breathability. Suitable materials include cellulosics such as rayon, wool, cotton, linen, thermoplastic fibers and combinations thereof. They may be woven or nonwoven.
Nonwoven rayon is a preferred substrate. Materials formed from combinations of cellulosic with thermoplastic fibers may also be employed. For instance, a hydrophilic polypropylene/rayon combination can be employed for the present invention.
It is advantageous to employ a ratio of composition to substrate sheet in amount ranging from 0.1:1 to 1,000:1, preferably 0.5:1 to 100:1 and optimally 0.8:1 to 10:1 by weight. The polymer ordinarily will constitute from 50 to 100, preferably from 75 to 990, optimally from 85 to 95o by weight of the composition deposited onto the substrate sheet.
Minor adjunct ingredients may also be included such as fragrances, opacifiers and colorants, each in their effective amounts to accomplish their respective functions.
The following examples will more fully illustrate the embodiments of this invention. All parts, percentages and proportions referred to herein and in the appended claims are by weight unless otherwise indicated.
_ 17 _ A variety of polymers were evaluated for their adhesive effects in removing keratotic plugs from the skin. The polymers listed in Table I below were coated onto a non-woven resin bonded rayon (1 ounce/square yard). A knife-over-roll was utilized in the coating operation. After coating, the non-woven polymer impregnated substrate sheets were dried at 75°C in a convection oven. They were then cut into small patches.
The test patches were applied to the face of panelists in an area containing several plugged pores. The plugged pores were counted. Water was applied to the patch and it was then placed aver the test area with wet side down. Next, the patch was allowed to dry whereupon it was peeled off.
The number of plugs removed were counted as they appeared on the adhesive patch. Percentage of plugs removed were calculated to reflect efficiency of the test product.
POLYMER $ DRIED o PLUGS REMOVED
POLYMER ON
NON-WOVEN
Dextrine 409 5-15 Polyvinyl Alcohol 441 10-20 Polyvinyl Acetate 347 30-40 Polyacrylamidomethylpropa 119 5-15 ne Sulfonic Acid Polyacrylamidomethylpropa 275 25 ne Sulfonic Acid Poly(methyl vinyl 113 90-100 ether/maleic anhydride) 98~ Poly(methyl vinyl 116 80-95 ether/maleic anhydride) +
2$
'2-amino-2-methyl-1-I
propanol 90~ Poly(methyl vinyl ether/maleic anhydride) 145 90-100 loo Polyacrylamido methylpropane Sulfonic Acid Poly(Methyl Vinyl Ether Malefic Anhydride) Gantrez S-97 BF
was coated by knife-over-roll (25 mil.) over various nonwoven materials. After coating, the nonwoven materials were dried at 75°C in a convection oven and then cut into small patches. The test procedure was similar to that reported under Example 1. Results are reported in Table II.
ALE II
' NONWOVEN % PLUGS PULLED OBSERVATIONS
PGI 5255 90-100 Nice a ppearance Rayon Resin bonded (1 oz./sq. yard) Veratec 9408810 70-100 Nice appearance:
Polyester/cellulose Nonwoven may be too Wet laid weak (1.2 oz/sq. yard) Veratec 2006094 40-60 Nice appearance Polypropylene Thermal Bond (.6 oz/sq. yard) Veratec 10 Poor appearance:
Polyethylene When used i n (.5 oz/sq. yard) application adhesive dried very slow.
The following experiments were conducted to demonstrate the efficacy of employing adhesive strips activated just prior to use by water in the delivery of skin benefiting agents.
More particularly, the experiments reported herein concerned delivery of Vitamin C for anti-oxidant benefits.
Livid Peroxida ~ nr~ T ~r For An i nx; c~anr A rivittv_ A vulnerable target for free radicals in facial skin is the lipids. Lipid peroxidation can lead to membrane fludity changes, altered activity of membrane-bound enzymes and receptors, changes in ion permeability, protein and DNA
damage and mutagenesis, which may contribute to atrributes of unhealthy skin. Lipid peroxidation can be induced in skin by W radiation, ozone, environmental pollutants and WO 98142303 PCTlEP98/01423 other stresses. Although not wishing to be bound by any theory, initiation of peroxidation is believed to involve the abstraction of a hydrogen atom from the methylene carbon located between two adjacent double bonds in a polyunsaturated fatty acid, resulting in the formation of a lipid radical, L. In the membrane bilayer, oxygen reacts with this lipid-free radical to generate a lipid peroxyl radical, LOO. This reaction is rapid, approaching the theoretical diffusion rate. The lipid peroxyl radical can then propagate the formation of other lipid radicals, while itself generating a lipid hydroperoxide, LOON.
Procedure And Results The study involved four panelists. An adhesive strip of approximate size 1 x 3 inches having Gantrez S-97 BF~ as described under Example 2 was coated onto PGI 5255 rayon sheet and cut into half. A first of the halves was employed as a blank or control strip. The other half was impregnated with an aqueous solution of ascorbic acid and then immediately dried in an oven to achieve a non-tacky strip.
This half of the original strip was wetted in conjunction with a blank, to regenerate tackiness. Both halves were then applied to the forehead of each panelist. Application on the forehead was for a period of 15 minutes.
After removal of the control and additive containing strips, a Sebutape sample was taken from each site at 30 minutes, 1 hour and 3 hours. In all experiments, sebum was collected using Instant Sebutapes (CuDerm Corporation, Dallas, TX, 1 cm2 sampling area) held on the panelist's forehead with even pressure for 15 seconds.
Plastic sampling areas were peeled away from cardboard backing. The Sebutape was then treated with 100 :1 of » .. .. ,. ........ ~ ~ ..
isopropanol in a test tube. The test tube was vortexed until the Sebutape was saturated. It was then analyzed for lipid hydroperoxide content using the K-Assay LPO-CC assay . kit (Kamiya Biochemical Company, Seattle WA). The assay measures lipid hydroxyperoxides as follows: In the presence of hemoglobin, lipid hydroperoxides are reduced to hydroxyl derivatives (lipid alcohols) and the 10-N-Methylcarbamoyl-3, 7-dimethylamino-10 H-phenothiazine (MCDP) chromagen is oxidatively cleaved to form methylene blue in an equal molar reaction. Lipid peroxides are then quantitated colorimetrically measuring the methylene blue at 675 nm (Kamiya Biochemical Company, assay protocol). LPO values are calculated according to the following equation:
LPO (nmol/ml) - (AbsorbancP SAMPT F Absorh~,nrP RT ~'~TK1 x 50 (Absorbance STANDARD - Absorbance BLANK) Results of the test are recorded under Table III.
TABLE III
PANELI BLANK 3% BLANK 3~s BLANK
ST ASCORBATE ASCORBATE ASCORBATE
1 72 98.4 47.9 68.9 90.4 69 2 39.2 70.4 54.3 43.1 .
139.5 202.6 BLANK 6% BLANK 6~ BLANK 6%
ASCORBATE ASCORBATE ASCORBATE
3 24 32 18.1 25 29.8 23 4 39.2 52.8 75.9 44.8 .
315.8 109.6 In the 30 minute sample, all of the four panelists had lower lipid hydroxyperoxide values on the control strip than on the ascorbate treated side. This result is believed to occur because the control adhered better than the ascorbate containing strips, thus pulling more lipids from the skin.
In the one hour sample, two of the four panelists on their ascorbate treated sides were found to have lower levels of lipid hydroperoxide than the control (blank) side.
Moreover, all of the ascorbate treated site values were lower than their original 30 minute readings. After three hours, three out of the four panelists on their ascorbate treated sides exhibited lower lipid hydroperoxide values than the control side. It is evident that over a period of time, the ascorbate was highly effective in its anti-oxidant performance against the skin.
The foregoing description and examples illustrate selected embodiments of the present invention by way of example only.
..
Most preferred among the esters are retinyl palmitate and . retinyl linoleate. Vitamin E may be provided in the form of tocotrienols, a-tocopherol, (3-tocopherol, y-tocopherol and 8-tocopherol. Included within the Vitamin E group are tocopheryl C2-C2z fatty acid esters including tocopheryl acetate, tocopherol linoleate and tocopheryl palmitate.
Vitamin B may be present in the form of thiamine, riboflavin, niacin, pantothenic acid, biotin, cobalamin, pyridoxine hydrochloric, pyridoxamine dihydrochloride, pyridoxal, pyridoxal phosphate, folic acid, inositol and mixtures as well as complexes thereof. Under the term vitamin may also be included thaproline, L-caritine, nicotinic acid, nicotinamide and cyproterone acetate.
Herbal extracts particularly suitable for the present invention are antioxidants or free-radical inhibitors.
Examples of these extracts include:
WO 98/42303 PCTlEP98/01423 _ 6 _ PLANT/EXTRACTS SOLUBILITY
W=WATER
O=OIL
basil leaf o and w bell a er o and w black tea extracts w blackber w black currant fruit w chamomile o carrot root o coffee seed w dandelion root o and w date alm fruit o and w echinacea ur urea o fennel o in ko leaf w insen o ra a seed o ra a skin o ra efruit o green tea polyphenyls (i.e. w including epicatechin gallate and a i allocaatechin 3-O- allate) a ali ids o har o o h tum o hawthorn berries w ' asmine o licorice w and o mar ' oram o rrh um resin o onion o ine bark o red clover flower o resveratrol o rosema o sa a w sesame o St. Johns wort o strawber w sweet ea w tomato o and w th a o Uva Ursi (bearber ) o vanilla fruit w bora a seed oil o wild bora a seed oil o Flavanoid Extracts hes eredin o ~neohesperidin ~ w uercetin o rutin -morin ' w kaem herol o ricetin w/o enistein o Ph toestro en Extracts coumestrol o estriol o h tosterols o Other Extracts limonene o etho uin o chloro enic acid w lutathione w h dro uinone o ubi uinone (coenz me Q) o li oic acid o N-acet 1 c steine o curcumin o Herbal extracts particularly effective for sebum/oil control include dill, horseradish, oats, neem, beet, broccoli, tea, pumpkin, soybean, barley, walnut, flax, ginseng, poppy, avocado, pea, sesame, dandelion, wheat, nettle, cashew, pineapple, apple, asparagus, Brazilnut, chickpea, grapefruit, orange, cucumber, buckwheat, strawberry, ginko, tomato, blueberry, cowpea and grape extracts.
Other herbal extracts also suitable are those of ivy horse chestnut, centella asiatica, rosmarinic acid, glycyrrizinate derivatives, alpha bisabolol, azulene and derivatives thereof, asiaticoside, sericoside, ruscogenin, escin, escolin, betulinic acid and derivatives thereof, catechin and derivatives thereof.
Alpha- and beta- hydroxycarboxylic acids ranging from Cz-C3o are also suitably delivered by the adhesive strips of the present invention. The beta-hydroxycarboxylic acids are primarily exemplified by salicylic acid and C1-C3o ester and _ g -salt derivatives. Examples of suitable alpha-hydroxycarboxylic acids include but are not limited to:
alpha hydroxy acetic acid (glycolic acid) alpha hydroxybenzeneacetic acid (mandelic acid) alpha hydroxypropionic acid (lactic acid) alpha hydroxybutanoic acid alpha hydroxyhexanoic acid alpha hydroxyoctanoic acid (alpha hydroxycaprylic acid) alpha hydroxynonanoic acid alpha hydroxydecanoic acid alpha hydroxyundecanoic acid alpha hydroxydodecanoic acid (alpha hydroxylauric acid) alpha hydroxytetradecanoic acid alpha hydrocyhexadecanoic acid alpha hydroxyoctadecanoic acid alpha hydroxyoctaeicosanoic acid;
dicarboxylic alpha hydroxy acids;
dihydroxybutanedioic acid (tartaric acid) 2-hydroxybutanedioic acid (malic acid) 2-hydroxy propanedioic acid 2-hydroxy hexanedioic acid 2-hydroxy octanedioic acid 2-hydroxy decanedioic acid 2-hydroxy dodecanedioic acid 2-hydroxy myristicdioic acid 2-hydroxy palmiticdioic acid Tricarboxylic alpha hydroxy acid;
2-hydroxy-1,2,3,-propanetricarboxylic acid (citric acid) 1-hydroxy-1,2,3-propanetricarboxylic acid (isocitric acid) and mixtures thereof.
C1-C3o esters and salts of alpha- and beta- hydroxycarboxylic acids (e. g. potassium , sodium, ammonium, triethanolammonium WO 98/42303 PCTlEP98/01423 - g -salts) are also meant to be included within the term "alpha-. and beta- hydroxycarboxylic acid". Depending on the pH of the composition, a mixture of the salt and the acid may be present.
The preferred alpha hydroxycarboxylic acids are monocarboxylic acids, in order to improve skin penetration and efficacy.
Even more preferably, the hydroxy acid is chosen from lactic acid, glycolic acid, mandelic acid, and mixtures thereof to optimize the efficacy of compositions by increasing percutaneous absorption. Most preferred is the L-form of an alpha hydroxycarboxylic acid.
Ceramides useful for the present invention are sphingolipids or phytosphingolipids including Ceramide 1, Ceramide 3 and Ceramide 6.
Anti-inflammatories of the present invention are illustrated by corticoids such as beta-methasone 17-acetate, indomethacin, ketoprofen, flufenamic acid, ibuprofen, diclofenace, diflunisal, fenclofenac, naproxen, piroxidam and sulindac. Antimicrobials illustrative of the present invention include, chlorohexidine, hexetidine, 3,4,4'-trichlorocarbanilide, (tricarbanilide) 2,4,4'-tricloro-2-hydroxydiphenyl ether (triclosan), cetyl pyridinium chloride, benzalkonium chloride, C~-Czo organoperoxy compounds (e.g, benzoyl peroxide) and mixtures. Vasoconstrictors are illustrated by compounds such as papaverine, yohimbine, ' visnadin, khellin, bebellin and nicotinate derivatives.
Zinc salts which may be effective include zinc thaproline, ' zinc chloride, zinc sulfate, zinc phenolsulfonate and zinc pyrithione. Other substances within one or more of the above categories of actives include resorcinol, azelaic acid, oxamic acid and cyoctol.
Actives of the present invention may range from 0.00002 to 40%, preferably from 0.01 to 20%, optimally from 0.1 to 10%
and in some instances from 1 to 8% by weight of the composition. Of course, vitamins and herbal extracts are usually employed at much lower levels than for instance the hydroxycarboxylic acids. Thus, vitamins may range from 0.0001 to 1%, preferably from 0.001 to 0.5% by weight for Vitamin A, Vitamin B and Vitamin E. Much higher levels may be tolerated for Vitamin C and these may range preferably from 0.01 to 40%, optimally from 0.1 to 30% by weight.
Preferably the amount of the hydroxycarboxylic acid component present in the composition according to the invention is from 0.5% to 20%, more preferably from 1% to 15%, and most preferably from 3.0% to 12.0% by weight of the composition.
Actives of the present invention will be formulated onto a flexible substrate sheet impregnated with an adhesive composition containing an anionic, cationic, nonionic, amphoteric or zwitterionic polymer. In a dry state, the composition preferably but not necessarily is non-tacky to the touch. The impregnated substrate sheet is sealably enclosed in a pouch, particularly a laminated foil package to control moisture level.
Pouches of the present invention are normally of the laminated foil variety. These are heat sealed and utilize foils with very low vapor (e. g. moisture) transmission rates (a rate of transmission less than 5% per day, preferably less than 1% per day volatile fluid gain or loss). Walls suitable for the pouch may utilize polyester, polyethylene or polypropylene sheets, several layers of which can be laminated together. These layers may also be provided with a coating of wax or other volatile fluid impermeable material.
The product is used by removing the strip from its usually individually wrapped pouch and either directly wetting the composition on the sheet or indirectly by wetting the face in areas to be contacted by the composition. In either instance, the wetting agent interacts with the composition so it becomes tacky and sufficiently mobile to flow into skin pores. The time between removal of strip from the pouch and use may be anywhere from 5 seconds to several hours, usually from 10 to 20 seconds. Pure water is the preferred wetting agent. However, other liquid systems or gels could be employed. Suitable wetting agents would include alcohols such as ethanol, propanol, propylene glycol, polyethylene glycol, polypropylene glycol and especially mixtures of these alcohols with water. Gels would normally consist of structured liquids (particularly water) thickened with structuring agents such as Carbomer.
Subsequent to wetting, the composition is allowed to dry over the area of treatment. During drying the keratotic plugs stickingly adhere to the composition. Advantageously the drying period ranges from 1 minute to 5 hours, preferably from 5 minutes to 1 hour, optimally from 10 to 20 minutes. Thereafter, the dried composition with adhered plugs is peeled from the skin.
Mobility of the composition may be measured by yield point.
The yield point should range from 1 to 400 Pascals, preferably from 20 to 200, optimally from 50 to 100 Pascals.
The composition will include an adhesive polymer which may either be anionic, cationic, nonionic, amphoteric, zwitter-ionic or mixtures thereof. Mixtures may be of polymers within any one categoxy or between different category types.
Illustrative of the latter, and a preferred embodiment, is a combination of an anionic and nonionic polymer.
Examples of nonionic polymers suitable for adhesive film deposition are the copolymers of vinyl acetate and crotonic acid, terpolymers of vinyl acetate, crotonic acid and a vinyl ester of an alpha-branched saturated aliphatic monocarboxylic acid such as vinyl neodecanoate; copolymers of methyl vinyl ether and malefic anhydride (molar ratio about 1.1) wherein such copolymers are 50°s esterified with a saturated alcohol containing from 1 to 4 carbon atoms such as ethanol or butanol; and acrylic copolymers, terpolymers, etc., containing acrylic acid or methacrylic acid esters of acrylic or methacrylic acid with one or more saturated alcohols having from 1 to 22 carbon atoms such as methyl methacrylate, ethyl acrylate, ethyl methacrylate, n-butyl acrylate, t-butyl acrylate, t-butyl methacrylate, n-butyl methacrylate, n-hexyl acrylate, n-octyl acrylate, lauryl methacrylate and behenyl acrylate, glycols having from 1 to 6 carbon atoms such as hydroxypropyl methacrylate and hydroxyethyl acrylate, styrene, vinyl caprolactam, vinyl acetate, acrylamide, alkyl acrylamides and methacrylamides having 1 to 8 carbon atoms in the alkyl group such as methacrylamide, t-butyl acrylamide and n-octyl acrylamide, and other compatible unsaturated monomers. One specific example is the emulsion polymerized terpolymer of methacrylic acid, n-butyl acrylate and ethyl acrylate (e. g., in a weight percent ratio of 31:42:27, respectively).
Further examples of nonionic adhesive polymers are homopolymers of N-vinylpyrrolidone and copolymers of ,.
N-vinylpyrrolidone with compatible nonionic monomers such as vinyl acetate and terpolymers of ethyl acrylate, butyl methacrylate and methyl methacrylate. Nonionic polymers containing N-vinylpyrrolidone in various weight average molecular weights are available commercially from ISP
Corporation such as homopolymers of N-vinylpyrrolidone having an average molecular weight of about 530,000 under the trademark PVP K-90 and those having an average molecular weight of about 1,000,000 sold under the trademark of PVP
K-120. Particularly preferred is poly(methyl vinyl ether/maleic anhydride) as an unneutralized resin available from ISP Corporation under the trademark Gantrez~ S-97 BF.
Anionic adhesive polymers often are derived from the nonionic types which include carboxylic acid functions.
Alkaline agents are employed to neutralize the carboxylic acid or anhydride transforming them into anionic salts.
Examples of suitable neutralizing agents include 2-amino-2-methyl-1,3-propanediol (AMPD);
2-amino-2-ethyl-1,3-propanediol (AEPD);
2-amino-2-methyl-1-propanol (AMP); 2-amino-1-butanol (AB);
monoethanolamine (MEA); diethanolamine (DEA);
triethanolamine (TEA); monoisopropanolamine (MIPA);
diisopropanol-amine (DIPA); triisopropanolamine (TIPA); and dimethyl stearamine (DMS). Most preferred is AMP.
Particularly preferred anionic polymers are the salts of poly(methyl vinyl ether/maleic anhydride) and polystyrene sulfonic acid. The former is obtained by at least partial neutralization of Gantrez~ S-97 BF and the latter available from the National Starch & Chemical Company under the trademarks Versa TL-501 and Flexan~ 130 having respective molecular weights of about 500,000 and 100,000. Other polymer films which may be employed and are commercially available as listed in the Table below.
TABLE I
POLYMER TRADEMARKS CTFA DESIGNATIONS
(SUPPLIER) Resyn~ 28-1310 (NSC) Vinyl acetate/crotonic acid copolymer Resyn~ 28-2930 (NSC) Vinyl acetate/crotonic acid/vinyl neodecanoate copolymer Resyn~ 28-2913 (NSC) Vinyl acetate/crotonic acid/vinyl neodecanoate copolymer Versatyl~ 40 (NSC) Octylacrylamide/acrylates copolymer Versatyl~ 42 (NSC) Octylaczylamide/acrylates copolymer Experimental Resin (NSC) Vinyl acetate/vinyl neodecanoate/maleic half-ester ',Ultrahold-8~ (BASF) Acrylate/acrylamide copolymer Luviset~ CAP (BASF) Vinyl acetate/crotonic acid/vinyl propionate copolymer PVP K-30 (ISP) PVP
PVP/VA E-335 (ISP) PVP/Vinyl acetate copolymer PVP/VA E-735 (ISP) PVP/Vinyl acetate copolymer Gantrez~ ES-225 (ISP) Ethyl ester of PVM/MA copolymer Gantrez~ ES-425 (ISP) Butyl ester of PVM/MA copolymer Gaffix~ VC-713 (ISP) Vinyl caprolactam/PVP/dimethyl aminoethyl methacrylate copolymer Cationic adhesive polymers suitable for the present invention may be prepared as homo- or copolymers from monomers including:
Dimethyl aminoethyl acrylate (DMAEA), Dimethylaminoethyl methacrylate (DMAEMA), Dimethylaminopropylacrylamide (DMAPAAm), and Dimethylaminopropyl methacrylamide (DMAPMAAm) which are all (meth)acrylamides or (meth)acrylic acid esters having a dialkylamino group;
,., Dimethylaminostyrene (DMASt) and Dimethyaminomethylstyrene (DMAMSt) and the like which are styrenes having a dialkylamino group;
4-Vinyl pyridine and 2-vinyl pyridine which are vinyl pyridines; and Quaternized products of these with a known quaternizing agent such as alkyl halide, benzyl halide, alkyl or aryl 20 sulfonic acid, or dialkyl sulfate.
Among suitable amphoteric adhesive polymers are those derived from monomers such as:
N-(3-sulfopropyl)-N-acryloyloxyethyl-N,N-dimethylammonium betaine, N-(3-sulfopropyl)-N-methacroylamidepropyl-N,N-dimethylammonium betaine, N-(3-carboxymethyl)-N-methacroylamidepropyl-N,N-dimethylammonium betaine and N-carboxymethyl-N-methacroylaxyethyl-N,N-dimethylammonium betaine.
When the salt forming group of the cationic and amphoteric polymers is not ionized, it is preferred to ionize it via neutralization with known acids such as hydrochloric acid and sulfuric acid which are inorganic acids; acetic acid, propionic acid, lactic acid, succinic acid, glycol acid which are organic acids, or with known bases such as triethylamine, trimethylarnine which are tertiary amines;
ammonia; or sodium hydroxide.
Most polymers suitable for the present invention will be relatively brittle when dried. Therefore, they require a supporting surface which is a flexible substrate sheet.
Substrate sheets of the present invention may either be occlusive or non-occlusive. Preferably but not necessarily the sheets are non-occlusive to allow water evaporation from the deposited polymer as the film maturates. Non-occlusivity or breathability is achieved either through use of a hydrophobic substrate having physical porosity (e. g.
pore channels) or a hydrophilic substrate wherein the material of construction inherently allows for breathability. Suitable materials include cellulosics such as rayon, wool, cotton, linen, thermoplastic fibers and combinations thereof. They may be woven or nonwoven.
Nonwoven rayon is a preferred substrate. Materials formed from combinations of cellulosic with thermoplastic fibers may also be employed. For instance, a hydrophilic polypropylene/rayon combination can be employed for the present invention.
It is advantageous to employ a ratio of composition to substrate sheet in amount ranging from 0.1:1 to 1,000:1, preferably 0.5:1 to 100:1 and optimally 0.8:1 to 10:1 by weight. The polymer ordinarily will constitute from 50 to 100, preferably from 75 to 990, optimally from 85 to 95o by weight of the composition deposited onto the substrate sheet.
Minor adjunct ingredients may also be included such as fragrances, opacifiers and colorants, each in their effective amounts to accomplish their respective functions.
The following examples will more fully illustrate the embodiments of this invention. All parts, percentages and proportions referred to herein and in the appended claims are by weight unless otherwise indicated.
_ 17 _ A variety of polymers were evaluated for their adhesive effects in removing keratotic plugs from the skin. The polymers listed in Table I below were coated onto a non-woven resin bonded rayon (1 ounce/square yard). A knife-over-roll was utilized in the coating operation. After coating, the non-woven polymer impregnated substrate sheets were dried at 75°C in a convection oven. They were then cut into small patches.
The test patches were applied to the face of panelists in an area containing several plugged pores. The plugged pores were counted. Water was applied to the patch and it was then placed aver the test area with wet side down. Next, the patch was allowed to dry whereupon it was peeled off.
The number of plugs removed were counted as they appeared on the adhesive patch. Percentage of plugs removed were calculated to reflect efficiency of the test product.
POLYMER $ DRIED o PLUGS REMOVED
POLYMER ON
NON-WOVEN
Dextrine 409 5-15 Polyvinyl Alcohol 441 10-20 Polyvinyl Acetate 347 30-40 Polyacrylamidomethylpropa 119 5-15 ne Sulfonic Acid Polyacrylamidomethylpropa 275 25 ne Sulfonic Acid Poly(methyl vinyl 113 90-100 ether/maleic anhydride) 98~ Poly(methyl vinyl 116 80-95 ether/maleic anhydride) +
2$
'2-amino-2-methyl-1-I
propanol 90~ Poly(methyl vinyl ether/maleic anhydride) 145 90-100 loo Polyacrylamido methylpropane Sulfonic Acid Poly(Methyl Vinyl Ether Malefic Anhydride) Gantrez S-97 BF
was coated by knife-over-roll (25 mil.) over various nonwoven materials. After coating, the nonwoven materials were dried at 75°C in a convection oven and then cut into small patches. The test procedure was similar to that reported under Example 1. Results are reported in Table II.
ALE II
' NONWOVEN % PLUGS PULLED OBSERVATIONS
PGI 5255 90-100 Nice a ppearance Rayon Resin bonded (1 oz./sq. yard) Veratec 9408810 70-100 Nice appearance:
Polyester/cellulose Nonwoven may be too Wet laid weak (1.2 oz/sq. yard) Veratec 2006094 40-60 Nice appearance Polypropylene Thermal Bond (.6 oz/sq. yard) Veratec 10 Poor appearance:
Polyethylene When used i n (.5 oz/sq. yard) application adhesive dried very slow.
The following experiments were conducted to demonstrate the efficacy of employing adhesive strips activated just prior to use by water in the delivery of skin benefiting agents.
More particularly, the experiments reported herein concerned delivery of Vitamin C for anti-oxidant benefits.
Livid Peroxida ~ nr~ T ~r For An i nx; c~anr A rivittv_ A vulnerable target for free radicals in facial skin is the lipids. Lipid peroxidation can lead to membrane fludity changes, altered activity of membrane-bound enzymes and receptors, changes in ion permeability, protein and DNA
damage and mutagenesis, which may contribute to atrributes of unhealthy skin. Lipid peroxidation can be induced in skin by W radiation, ozone, environmental pollutants and WO 98142303 PCTlEP98/01423 other stresses. Although not wishing to be bound by any theory, initiation of peroxidation is believed to involve the abstraction of a hydrogen atom from the methylene carbon located between two adjacent double bonds in a polyunsaturated fatty acid, resulting in the formation of a lipid radical, L. In the membrane bilayer, oxygen reacts with this lipid-free radical to generate a lipid peroxyl radical, LOO. This reaction is rapid, approaching the theoretical diffusion rate. The lipid peroxyl radical can then propagate the formation of other lipid radicals, while itself generating a lipid hydroperoxide, LOON.
Procedure And Results The study involved four panelists. An adhesive strip of approximate size 1 x 3 inches having Gantrez S-97 BF~ as described under Example 2 was coated onto PGI 5255 rayon sheet and cut into half. A first of the halves was employed as a blank or control strip. The other half was impregnated with an aqueous solution of ascorbic acid and then immediately dried in an oven to achieve a non-tacky strip.
This half of the original strip was wetted in conjunction with a blank, to regenerate tackiness. Both halves were then applied to the forehead of each panelist. Application on the forehead was for a period of 15 minutes.
After removal of the control and additive containing strips, a Sebutape sample was taken from each site at 30 minutes, 1 hour and 3 hours. In all experiments, sebum was collected using Instant Sebutapes (CuDerm Corporation, Dallas, TX, 1 cm2 sampling area) held on the panelist's forehead with even pressure for 15 seconds.
Plastic sampling areas were peeled away from cardboard backing. The Sebutape was then treated with 100 :1 of » .. .. ,. ........ ~ ~ ..
isopropanol in a test tube. The test tube was vortexed until the Sebutape was saturated. It was then analyzed for lipid hydroperoxide content using the K-Assay LPO-CC assay . kit (Kamiya Biochemical Company, Seattle WA). The assay measures lipid hydroxyperoxides as follows: In the presence of hemoglobin, lipid hydroperoxides are reduced to hydroxyl derivatives (lipid alcohols) and the 10-N-Methylcarbamoyl-3, 7-dimethylamino-10 H-phenothiazine (MCDP) chromagen is oxidatively cleaved to form methylene blue in an equal molar reaction. Lipid peroxides are then quantitated colorimetrically measuring the methylene blue at 675 nm (Kamiya Biochemical Company, assay protocol). LPO values are calculated according to the following equation:
LPO (nmol/ml) - (AbsorbancP SAMPT F Absorh~,nrP RT ~'~TK1 x 50 (Absorbance STANDARD - Absorbance BLANK) Results of the test are recorded under Table III.
TABLE III
PANELI BLANK 3% BLANK 3~s BLANK
ST ASCORBATE ASCORBATE ASCORBATE
1 72 98.4 47.9 68.9 90.4 69 2 39.2 70.4 54.3 43.1 .
139.5 202.6 BLANK 6% BLANK 6~ BLANK 6%
ASCORBATE ASCORBATE ASCORBATE
3 24 32 18.1 25 29.8 23 4 39.2 52.8 75.9 44.8 .
315.8 109.6 In the 30 minute sample, all of the four panelists had lower lipid hydroxyperoxide values on the control strip than on the ascorbate treated side. This result is believed to occur because the control adhered better than the ascorbate containing strips, thus pulling more lipids from the skin.
In the one hour sample, two of the four panelists on their ascorbate treated sides were found to have lower levels of lipid hydroperoxide than the control (blank) side.
Moreover, all of the ascorbate treated site values were lower than their original 30 minute readings. After three hours, three out of the four panelists on their ascorbate treated sides exhibited lower lipid hydroperoxide values than the control side. It is evident that over a period of time, the ascorbate was highly effective in its anti-oxidant performance against the skin.
The foregoing description and examples illustrate selected embodiments of the present invention by way of example only.
..
Claims (9)
1. A cosmetic product for delivery of skin actives is provided which includes:
(A) a strip comprising:
(i) a flexible substrate sheet; and (ii) a composition containing a polymer selected from the group consisting of anionic, cationic, nonionic, amphoteric, zwitterionic and polymer mixtures thereof deposited onto the substrate sheet, wherein the amount of polymer ranges from 75 to 99% by weight of composition deposited onto the substrate sheet, the composition further comprising an active selected from the group consisting of vitamins, herbal extracts, alpha- and beta- hydroxycarboxylic acids, ceramides, anti-inflammatories, antimicrobials, vasoconstrictors, zinc salts and mixtures thereof; the composition increasing in tackiness upon being wetted just prior to use thereby enhancing the composition adhesivity to skin; and (B) a pouch sealably enclosing the strip.
(A) a strip comprising:
(i) a flexible substrate sheet; and (ii) a composition containing a polymer selected from the group consisting of anionic, cationic, nonionic, amphoteric, zwitterionic and polymer mixtures thereof deposited onto the substrate sheet, wherein the amount of polymer ranges from 75 to 99% by weight of composition deposited onto the substrate sheet, the composition further comprising an active selected from the group consisting of vitamins, herbal extracts, alpha- and beta- hydroxycarboxylic acids, ceramides, anti-inflammatories, antimicrobials, vasoconstrictors, zinc salts and mixtures thereof; the composition increasing in tackiness upon being wetted just prior to use thereby enhancing the composition adhesivity to skin; and (B) a pouch sealably enclosing the strip.
2. The product according to claim 1 wherein the vitamins are selected from the group consisting of Vitamin A, Vitamin B, Vitamin C, Vitamin E and combinations thereof.
3. The product according to claim 2 wherein the Vitamin C
is selected from the group consisting of ascorbic acid, magnesium ascorbyl phosphate, ascorbyl palmitate, L-ascorbyl stearate, dehydroascorbic acid, vitazyme C and combinations thereof.
is selected from the group consisting of ascorbic acid, magnesium ascorbyl phosphate, ascorbyl palmitate, L-ascorbyl stearate, dehydroascorbic acid, vitazyme C and combinations thereof.
4. The product according to any preceding claim wherein the amount of active ranges from 0.00001 to 40% by weight.
5. The product according to any preceding claim wherein the sheet is rayon.
6. The product according to any preceding claim wherein the composition and substrate sheet are present in a weight ratio ranging from 0.1:1 to 1,000:1.
7. The product according to any preceding claim wherein the polymer is a polyvinyl pyrrolidone.
8. The product according to any preceding claim wherein the polymer is a poly(methyl vinyl ether/maleic anhydride) copolymer.
9. Use of the product according to any preceding claim for the delivery of moisture sensitive actives, selected from the group comprising vitamins, herbal extracts, alpha- and beta- hydroxycarboxylic acids, ceramides, anti-inflammatories, anti-microbials, vasoconstrictors, zinc salts and mixtures thereof, to the skin.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3937897P | 1997-03-20 | 1997-03-20 | |
| US60/039378 | 1997-03-20 | ||
| US7235598P | 1998-01-23 | 1998-01-23 | |
| US60/072355 | 1998-01-23 | ||
| PCT/EP1998/001423 WO1998042303A1 (en) | 1997-03-20 | 1998-03-10 | Cosmetic product |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2282442A1 true CA2282442A1 (en) | 1998-10-01 |
Family
ID=26716077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002282442A Abandoned CA2282442A1 (en) | 1997-03-20 | 1998-03-10 | Cosmetic product |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US5935596A (en) |
| EP (1) | EP0969806B1 (en) |
| JP (1) | JP2002510285A (en) |
| CN (1) | CN1255847A (en) |
| AT (1) | ATE222091T1 (en) |
| AU (1) | AU731691B2 (en) |
| BR (1) | BR9808272A (en) |
| CA (1) | CA2282442A1 (en) |
| CO (1) | CO4940354A1 (en) |
| CZ (1) | CZ290967B6 (en) |
| DE (1) | DE69807197T2 (en) |
| EA (1) | EA002132B1 (en) |
| ES (1) | ES2182291T3 (en) |
| ID (1) | ID23787A (en) |
| MY (1) | MY114940A (en) |
| PL (1) | PL335764A1 (en) |
| WO (1) | WO1998042303A1 (en) |
Families Citing this family (90)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5512277A (en) | 1991-05-15 | 1996-04-30 | Kao Corporation | Keratotic plug remover |
| FR2706143B1 (en) | 1993-06-07 | 1995-08-11 | Oreal | Method for molding a makeup composition and makeup product obtained. |
| WO1998052560A1 (en) | 1997-05-21 | 1998-11-26 | Sloan-Kettering Institute For Cancer Research | Method for increasing the concentration of ascorbic acid in brain tissues of a subject |
| US6262111B1 (en) | 1997-05-21 | 2001-07-17 | Sloan-Kettering Institute For Cancer Research | Method for increasing the concentration of ascorbic acid in brain tissues of a subject |
| IT1298228B1 (en) * | 1998-02-11 | 1999-12-20 | Biofarm Srl | PATCH TO REMOVE THE COMEDONES FROM THE SKIN |
| US6106857A (en) * | 1998-03-10 | 2000-08-22 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Fragranced cosmetic product for removal of keratotic plugs from skin pores |
| FR2781668B1 (en) * | 1998-07-31 | 2001-06-01 | Oreal | SKIN TREATMENT PROCESS AND PATCH FOR IMPLEMENTING THE PROCESS |
| US6623751B2 (en) | 1998-07-30 | 2003-09-23 | L'oreal S.A. | Cosmetic, pharmaceutical, or dermatological patch |
| US6063390A (en) | 1998-08-07 | 2000-05-16 | Chesebrough-Pond's Usa Co., A Division Of Conopco, Inc. | Cosmetic effervescent cleansing pillow |
| AU6034599A (en) * | 1998-09-10 | 2000-03-27 | Avon Products Inc. | Method and compositions for reducing dermatological aging and for reducing bruising |
| US20040131579A1 (en) * | 1998-09-10 | 2004-07-08 | Avon Products, Inc. | Method and compositions for reducing dermatological aging and for reducing bruising |
| DE19911262C2 (en) * | 1999-03-13 | 2003-04-10 | Scs Skin Care Systems Gmbh | Device for dispensing cosmetic active ingredients |
| US6294182B1 (en) | 1999-03-18 | 2001-09-25 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Towelette product for minimizing facial fine lines and wrinkles |
| US6800292B1 (en) * | 1999-04-22 | 2004-10-05 | Howard Murad | Pomegranate fruit extract compositions for treating dermatological disorders |
| US6630163B1 (en) * | 1999-04-22 | 2003-10-07 | Howard Murad | Method of treating dermatological disorders with fruit extracts |
| US6210701B1 (en) * | 1999-04-30 | 2001-04-03 | Healthcomm International, Inc. | Medical food for treating inflammation-related diseases |
| WO2000069397A1 (en) * | 1999-05-12 | 2000-11-23 | Kao Corporation | Sebaceous-horn remover |
| US6296869B1 (en) * | 1999-07-30 | 2001-10-02 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Adhesive cosmetic patch containing alpha or beta hydroxy acids |
| GB9918022D0 (en) * | 1999-07-30 | 1999-09-29 | Unilever Plc | Skin care composition |
| US7354423B2 (en) | 1999-08-09 | 2008-04-08 | J&J Consumer Co., Inc. | Skin abrasion system and method |
| US6645184B1 (en) * | 1999-08-09 | 2003-11-11 | Brian D. Zelickson | Tape stripping system and method |
| US6306412B1 (en) | 1999-08-13 | 2001-10-23 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Cosmetic strip with an agent for inducing a temperature change |
| US6270783B1 (en) | 1999-08-13 | 2001-08-07 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Cosmetic strips with liquid crystal temperature dependent color change |
| AU7880700A (en) * | 1999-08-16 | 2001-03-13 | Dung Phan | Compositions and methods of treatment for skin conditions using extracts of turmeric |
| US6287582B1 (en) * | 1999-08-24 | 2001-09-11 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Towelette product |
| US6358517B1 (en) * | 1999-10-22 | 2002-03-19 | Unilever Home & Personal Care Usa, Division Of Conopco | Cosmetic compositions containing resveratrol and retinoids |
| JP2003514001A (en) * | 1999-11-16 | 2003-04-15 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Beauty composition comprising chickpea extract and retinoid |
| US6342561B1 (en) | 1999-11-17 | 2002-01-29 | 3M Innovative Properties Company | Organic particulate-filled adhesive |
| AU1784301A (en) * | 1999-11-24 | 2001-06-04 | Alticor Inc. | Topical skin composition |
| FR2801788B1 (en) * | 1999-12-01 | 2002-03-01 | Daniel Jouvance Rech S Et Crea | COSMETIC COMPOSITION WITH REDOX POTENTIAL STABILIZED BY THE REDOX COUPLE ASCORBIC ACID / DEHYDRO-ASCORBIC ACID |
| FR2804870B1 (en) * | 2000-02-16 | 2002-08-16 | Oreal | COMPOSITE STRUCTURE WITH ADHESIVE MATRIX CONTAINING ONE OR MORE ACTIVE INGREDIENTS |
| FR2805720B1 (en) | 2000-03-03 | 2002-08-16 | Oreal | DEVICE INCLUDING AN APPLICATOR AND / OR A MAGNETIC SPINNER |
| US6861077B1 (en) | 2000-03-17 | 2005-03-01 | L'oreal S.A. | Use of plant extracts in a cosmetic composition to protect keratinous fibers |
| IT1318425B1 (en) * | 2000-03-24 | 2003-08-25 | D B P Dev Biotechnological Pro | USE OF RESVERATROL FOR THE TREATMENT OF DESQUAMATIVE ECZEMA, ACNE AND PSORIASIS. |
| US7658942B2 (en) | 2000-04-12 | 2010-02-09 | The Procter & Gamble Company | Cosmetic devices |
| US7147859B2 (en) * | 2000-05-15 | 2006-12-12 | Laboratorios Biosintetica Ltda. | Application of phytosterols (and their isomers), folic acid, cyanocobalamin and pyridoxin in dietetic (alimentary) fibers |
| JP2002047125A (en) * | 2000-05-26 | 2002-02-12 | Shiseido Co Ltd | Skin care preparation for inhibiting sebum secretion |
| EP1196062B1 (en) | 2000-07-12 | 2005-10-26 | L'oreal | Device for packaging and/or applying a product containing fibres comprising at least a magnetised or magnetizable element |
| GB0023440D0 (en) * | 2000-09-25 | 2000-11-08 | Reckitt Benckiser Uk Ltd | Improvements in or relating to organic compositions |
| US20080124409A1 (en) * | 2000-11-21 | 2008-05-29 | Access Business Group International Llc | Topical Skin Compositions, Their Preparation, and Their Use |
| US20070003536A1 (en) * | 2000-11-21 | 2007-01-04 | Zimmerman Amy C | Topical skin compositions, their preparation, and their use |
| US8360973B2 (en) | 2000-11-29 | 2013-01-29 | L'oreal | Process for acquiring scanned image data relating to an external body portion and/or a product applied thereto |
| US20020123150A1 (en) * | 2000-12-21 | 2002-09-05 | Zeenat Nabi | Method |
| WO2002049679A2 (en) * | 2000-12-21 | 2002-06-27 | Polymer Group Inc. | Method for controlling noisome decomposition byproducts from human efflux retained in personal hygiene products |
| WO2002054997A1 (en) * | 2001-01-09 | 2002-07-18 | Lavipharm Laboratories Inc. | Devices for local and systemic delivery of active substances and methods of manufacturing thereof |
| US6500408B2 (en) * | 2001-01-27 | 2002-12-31 | Jc Technologies, Inc. | Enamel-safe tooth bleach and method for use |
| US6937749B2 (en) * | 2001-03-02 | 2005-08-30 | L'oreal | Process, system, and kit for evaluating the relief of the skin with a substrate |
| FR2822711B1 (en) * | 2001-03-28 | 2003-06-13 | Oreal | TREATMENT DEVICE COMPRISING AN ENVELOPE DEFINING A CAVITY IN WHICH A PART OF THE BODY MAY BE ENGAGED |
| US6676028B2 (en) | 2001-04-23 | 2004-01-13 | Howard Jacobson | Electrical resistance foot warmer for use with a motor vehicle |
| DE10121092A1 (en) * | 2001-04-26 | 2002-10-31 | Beiersdorf Ag | Cosmetic or dermatological formulations containing sericoside and / or plant extracts containing the same |
| FR2825246B1 (en) * | 2001-06-05 | 2004-06-04 | Oreal | PACKAGING AND/OR APPLICATION DEVICE COMPRISING FIBERS COMPRISING PARTICLES CAPABLE OF ABSORBING A LIQUID OR A COMPOUND IN SOLUTION IN THIS LIQUID OR OF DISSOLVING IN A LIQUID |
| FR2828399B1 (en) * | 2001-08-07 | 2005-06-17 | Soc Extraction Principes Actif | USE OF EXTRACT OF DATES TO TREAT CUTANEOUS MANIFESTATIONS OF AGING |
| US6869519B2 (en) * | 2001-09-27 | 2005-03-22 | National Institute Of Advanced Industrial Science And Technology | Electrolytic process for the production of metallic copper and apparatus therefor |
| US20030118536A1 (en) * | 2001-11-06 | 2003-06-26 | Rosenbloom Richard A. | Topical compositions and methods for treatment of adverse effects of ionizing radiation |
| WO2003066014A1 (en) * | 2002-02-08 | 2003-08-14 | Societe D'extraction Des Principes Actifs (Vincience Sa) | Use of a hsp inducing compound to limit secondary effects of retinoids |
| FR2841132B1 (en) * | 2002-06-19 | 2005-05-13 | USE OF EXTRACT OF DATE CORES AS SUBSTITUTE OF DHEA | |
| US20040096484A1 (en) * | 2002-11-19 | 2004-05-20 | Tyrrell David J. | Antioxidant-containing wipes and absorbent products for improving skin health |
| US7037535B2 (en) * | 2002-11-19 | 2006-05-02 | Kimberly-Clark Worldwide, Inc. | Method and composition for neutralizing house dust mite feces |
| US7585518B2 (en) | 2002-11-19 | 2009-09-08 | Kimberly-Clark Worldwide, Inc. | Products and methods for maintaining or increasing ceramide levels in skin |
| DE10308852A1 (en) * | 2003-02-27 | 2004-09-09 | Rovi Gmbh & Co. Kosmetische Rohstoffe Kg | Use of spasmolytics in liposomes and/or cerasomes in the production of agents for use in countering muscular spasms or as anti-wrinkle agents |
| US20050019379A1 (en) * | 2003-07-22 | 2005-01-27 | Kimberly-Clark Worldwide, Inc. | Wipe and methods for improving skin health |
| JP2007508320A (en) * | 2003-10-10 | 2007-04-05 | アクセス ビジネス グループ インターナショナル エルエルシー | A composition comprising rosmarinusofficinalis plant extract, Centella, Echinacea or Alpinia plant extract, and DNA repair enzyme |
| US20050143754A1 (en) * | 2003-12-31 | 2005-06-30 | Zelickson Brian D. | Skin abrasion system and method |
| US7268104B2 (en) * | 2003-12-31 | 2007-09-11 | Kimberly-Clark Worldwide, Inc. | Color changing liquid cleansing products |
| US20050196354A1 (en) * | 2004-03-03 | 2005-09-08 | Andre Soshinsky | Film compositions |
| JP2007526294A (en) * | 2004-03-03 | 2007-09-13 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | Film composition |
| US20050196355A1 (en) * | 2004-03-03 | 2005-09-08 | Constantine Georgiades | Film products having controlled disintegration properties |
| US20050196348A1 (en) * | 2004-03-03 | 2005-09-08 | Constantine Georgiades | Stabilized peroxide compositions |
| US20070269519A1 (en) * | 2004-03-03 | 2007-11-22 | Constantine Georgiades | Whitening products |
| US7294340B2 (en) * | 2004-03-30 | 2007-11-13 | Chien-Min Sung | Healthcare and cosmetic compositions containing nanodiamond |
| US8481007B2 (en) | 2004-03-30 | 2013-07-09 | Chien-Min Sung | Compositions and methods for providing ultraviolet radiation protection |
| ES2387129T3 (en) * | 2004-06-09 | 2012-09-14 | Laboratoire Nuxe | Composition comprising a blue lotus extract for the treatment of uncontrolled facial myoclonus |
| FR2871380B1 (en) * | 2004-06-09 | 2006-09-22 | Nuxe Sa Lab | COMPOSITION COMPRISING A VEGETABLE EXTRACT WITH DECONTRACTING EFFECT OF THE SKIN |
| US20060008538A1 (en) * | 2004-07-07 | 2006-01-12 | Wu Jeffrey M | Methods of treating the skin |
| AR054805A1 (en) * | 2005-06-29 | 2007-07-18 | Stiefel Laboratories | TOPICAL COMPOSITIONS FOR SKIN TREATMENT |
| US9107844B2 (en) * | 2006-02-03 | 2015-08-18 | Stiefel Laboratories Inc. | Topical skin treating compositions |
| PL2206494T3 (en) | 2006-03-31 | 2016-06-30 | Stiefel Res Australia Pty Ltd | Foamable suspension gel |
| EP2124907B1 (en) | 2007-03-19 | 2018-05-30 | Vita Sciences, Llc | Transdermal patch and method for delivery of vitamin b12 |
| JP2009005919A (en) * | 2007-06-28 | 2009-01-15 | Nippon Paper Papylia Co Ltd | Sheet-shaped cosmetic product |
| US20090241242A1 (en) * | 2008-03-31 | 2009-10-01 | Heidi Beatty | Facial mask |
| EP3078364A1 (en) | 2009-05-26 | 2016-10-12 | The General Hospital Corporation | Composition comprising metallic nanoparticles for use in the treatment of acne |
| EP3673893A1 (en) | 2010-08-27 | 2020-07-01 | Sienna Biopharmaceuticals, Inc. | Compositions and methods for targeted thermomodulation |
| US9572880B2 (en) | 2010-08-27 | 2017-02-21 | Sienna Biopharmaceuticals, Inc. | Ultrasound delivery of nanoparticles |
| US20130315999A1 (en) * | 2012-04-20 | 2013-11-28 | The General Hospital Corporation | Compositions and methods comprising energy absorbing compoundfs for follicular delivery |
| WO2014058904A1 (en) | 2012-10-11 | 2014-04-17 | Nanocomposix, Inc. | Silver nanoplate compositions and methods |
| CN104902867A (en) | 2012-12-11 | 2015-09-09 | 积水精细化工美国有限公司 | Pvoh copolymers for personal care applications |
| WO2016050626A1 (en) * | 2014-09-29 | 2016-04-07 | Koninklijke Philips N.V. | Skin cleaning device and method |
| US11109661B2 (en) | 2016-07-26 | 2021-09-07 | New You Lift, LLC | System, device and method of facial remodeling |
| WO2018190264A1 (en) * | 2017-04-10 | 2018-10-18 | 花王株式会社 | Skin cleanser composition |
| KR20200035899A (en) * | 2018-09-27 | 2020-04-06 | 주식회사 엘지화학 | A biocellulose sheet and a method for preparing thereof |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT206114B (en) * | 1955-03-23 | 1959-11-10 | Friedl Schreyer | Means for tensioning the skin of the face and process for its manufacture |
| US4126142A (en) * | 1977-04-20 | 1978-11-21 | Saute Robert E | Face mask |
| JPS55127312A (en) * | 1979-03-23 | 1980-10-02 | Kishiyouhin Kagaku Kaihou Kenkyusho:Kk | Pack cosmetic |
| JPS56120577A (en) * | 1980-02-21 | 1981-09-21 | Nippon Steel Corp | Blast furnace tap hole material |
| JPS56119499A (en) * | 1980-02-23 | 1981-09-19 | Kyosan Electric Mfg | Slide target unit |
| JPS57166514U (en) * | 1981-04-16 | 1982-10-20 | ||
| JPS5821609A (en) * | 1981-07-31 | 1983-02-08 | Kenji Nakamura | Cosmetic pack sheet and its preparation |
| FR2538247B1 (en) * | 1982-12-23 | 1986-05-23 | Pere Lahaille Jeanne | ANTI-WRINKLE AND / OR SKIN TREATING TABLET |
| FR2549842B1 (en) * | 1983-07-25 | 1988-01-29 | Oreal | COPOLYMERS OF ACRYLIC OR METHACRYLIC ACID, AN ALKYL ACRYLATE OR METHACRYLATE AND AN ALLYL DERIVATIVE, AND THEIR USE IN COSMETICS |
| SE455466C (en) * | 1986-03-10 | 1993-06-17 | Moelnlycke Ab | Conveyor Belt for Dangerous Sores |
| US4752472A (en) * | 1986-03-25 | 1988-06-21 | Exovir, Inc. | Cosmetic skin treatment useing cyanoacrylate polymer film |
| JPS6335511A (en) * | 1986-07-30 | 1988-02-16 | Shiseido Co Ltd | Pack cosmetic |
| JPS6357508A (en) * | 1986-08-28 | 1988-03-12 | Mikimoto Seiyaku Kk | Film-forming cosmetic pack |
| US4762124A (en) * | 1986-10-28 | 1988-08-09 | Kimberly-Clark Corporation | Liquid dispensing pouch |
| FR2620914B1 (en) * | 1987-09-25 | 1991-11-08 | Oreal | SHEET MATERIAL FOR PERFORMING SKIN OR HAIR TREATMENT, METHOD FOR MANUFACTURING SAME, AND ARTICLES MADE THEREOF |
| US4990339A (en) * | 1987-11-16 | 1991-02-05 | H. B. Fuller Company | Dermal treatment film |
| JP3046346B2 (en) * | 1990-03-12 | 2000-05-29 | 昭和電工株式会社 | External preparation base or auxiliary agent and human or animal external preparation containing it |
| DE69230509T2 (en) * | 1991-05-15 | 2000-05-04 | Kao Corp | Keratinous comedone remover |
| US5512277A (en) * | 1991-05-15 | 1996-04-30 | Kao Corporation | Keratotic plug remover |
| US5811107A (en) * | 1991-09-19 | 1998-09-22 | Smithkline Beecham Corporation | Skin cleanser |
| DE69231335T2 (en) * | 1991-09-19 | 2001-02-01 | Smithkline Beecham Corp | SKIN CLEANER |
| US5466456A (en) * | 1991-11-27 | 1995-11-14 | Glover; Morris S. | Facial cleanser |
| FR2715563B1 (en) * | 1994-01-31 | 1996-03-15 | Oreal | Stabilized emulsion, intended to hydrate the skin and its use. |
| WO1996014822A1 (en) * | 1994-11-15 | 1996-05-23 | Osmotics Corporation | Skin care compositions and methods |
| FR2734574A1 (en) * | 1995-05-24 | 1996-11-29 | Pacific Corp | Adhesive formulation for cosmetic and medical use |
| JPH09194325A (en) * | 1996-01-22 | 1997-07-29 | Nitto Denko Corp | Tack sheet for removing stain |
| JP2935343B2 (en) * | 1996-03-04 | 1999-08-16 | 花王株式会社 | Sheet pack |
| JPH09295929A (en) * | 1996-05-02 | 1997-11-18 | 宰賢 ▲べ▼ | Skin tack type cosmetic for removing crease of skin and its production |
| US5736128A (en) * | 1996-05-14 | 1998-04-07 | Isp Investments Inc. | Cosmetic composition for rejuvenation of skin without skin irritation |
| JP3034427U (en) * | 1996-08-05 | 1997-02-18 | 花王株式会社 | Nose pack |
-
1998
- 1998-02-04 US US09/018,805 patent/US5935596A/en not_active Expired - Fee Related
- 1998-03-10 ES ES98913708T patent/ES2182291T3/en not_active Expired - Lifetime
- 1998-03-10 PL PL98335764A patent/PL335764A1/en unknown
- 1998-03-10 AT AT98913708T patent/ATE222091T1/en not_active IP Right Cessation
- 1998-03-10 BR BR9808272-8A patent/BR9808272A/en not_active IP Right Cessation
- 1998-03-10 CA CA002282442A patent/CA2282442A1/en not_active Abandoned
- 1998-03-10 CN CN98805109A patent/CN1255847A/en active Pending
- 1998-03-10 DE DE69807197T patent/DE69807197T2/en not_active Expired - Fee Related
- 1998-03-10 EA EA199900847A patent/EA002132B1/en not_active IP Right Cessation
- 1998-03-10 AU AU68308/98A patent/AU731691B2/en not_active Ceased
- 1998-03-10 CZ CZ19993328A patent/CZ290967B6/en not_active IP Right Cessation
- 1998-03-10 ID IDW991057A patent/ID23787A/en unknown
- 1998-03-10 WO PCT/EP1998/001423 patent/WO1998042303A1/en active IP Right Grant
- 1998-03-10 EP EP98913708A patent/EP0969806B1/en not_active Expired - Lifetime
- 1998-03-10 JP JP54481498A patent/JP2002510285A/en active Pending
- 1998-03-18 CO CO98015205A patent/CO4940354A1/en unknown
- 1998-03-18 MY MYPI98001195A patent/MY114940A/en unknown
- 1998-12-03 US US09/204,567 patent/US5985300A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ATE222091T1 (en) | 2002-08-15 |
| CZ290967B6 (en) | 2002-11-13 |
| WO1998042303A1 (en) | 1998-10-01 |
| DE69807197T2 (en) | 2002-12-05 |
| DE69807197D1 (en) | 2002-09-19 |
| PL335764A1 (en) | 2000-05-22 |
| CO4940354A1 (en) | 2000-07-24 |
| EP0969806A1 (en) | 2000-01-12 |
| ID23787A (en) | 2000-05-11 |
| EA199900847A1 (en) | 2000-04-24 |
| BR9808272A (en) | 2000-05-16 |
| EA002132B1 (en) | 2001-12-24 |
| US5935596A (en) | 1999-08-10 |
| CZ332899A3 (en) | 2000-02-16 |
| AU6830898A (en) | 1998-10-20 |
| MY114940A (en) | 2003-02-28 |
| CN1255847A (en) | 2000-06-07 |
| JP2002510285A (en) | 2002-04-02 |
| ES2182291T3 (en) | 2003-03-01 |
| EP0969806B1 (en) | 2002-08-14 |
| AU731691B2 (en) | 2001-04-05 |
| US5985300A (en) | 1999-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU731691B2 (en) | Cosmetic product | |
| US6270783B1 (en) | Cosmetic strips with liquid crystal temperature dependent color change | |
| US6306412B1 (en) | Cosmetic strip with an agent for inducing a temperature change | |
| CA2088033C (en) | Water dispersible towelette impregnated with non-aqueous lotion formulations | |
| US6494856B1 (en) | Swab deliverable actives | |
| US6488646B1 (en) | Swab deliverable actives | |
| AU725041B2 (en) | Keratotic plug remover | |
| CA2265791C (en) | External preparations containing watercress extract | |
| CZ284034B6 (en) | Pharmaceutical, optionally biologically active preparation with increased transdermal penetration of medicaments contained therein | |
| US6174536B1 (en) | Cosmetic product for removal of keratotic plugs from skin pores | |
| US5968537A (en) | Cosmetic product for removal of keratotic plugs from skin pores | |
| MXPA99008317A (en) | Cosmetic product | |
| WO1999038473A2 (en) | Cosmetic product kit | |
| US20020051796A1 (en) | Solution of a polymer of the polyacrylic and/or polyvinylic type associated with a filler and a keratolytic agent, and a cosmetic device for cleaning and care of the skin | |
| JP2003116908A (en) | Patch | |
| WO1999037281A1 (en) | Skin care cosmetic method and system | |
| JPH1135446A (en) | Photo-sensitive element-containing adhesive composition and photo-sensitive adhesive sheet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |